Read More Healthcare Industry News Merit Medical (NASDAQ: MMSI) bets on C2 CryoBalloon technology—can this $22m deal redefine its GI strategy? Merit Medical (MMSI) will acquire the C2 CryoBalloon from Pentax for $22M to expand its GI therapy portfolio. Explore deal impact, investor sentiment, and growth outlook. byVenkateshOctober 16, 2025